Literature DB >> 25975547

[Characteristics of co-morbid psychiatric disability and injury caused disability in Chinese population].

Tianli Liu1, Lihua Pang1, Xu Wen1, Gong Chen1, Xiaoying Zheng2.   

Abstract

OBJECTIVE: To investigate the relations between psychiatric disability and co-morbid disability caused by injury, severity of the disabilities, as well as the unmet health care need among people living with both disabilities.
METHODS: Data collected through both the Second China National Sample Survey on Disabilities in 2006 and the Follow-up Studies in 2009, were utilized. Sampling weights were considered to appropriately estimate situations in the total Chinese population.
RESULTS: Among people with psychiatric disability, 2.7% of them were affected by other injury-caused disabilities as visual, hearing, speech, psychical and intellectual disabilities. Among people with disability that caused by injuries, 1.8% of them were living with psychiatric disability as well. The prevalence rates of psychiatric disability and injury caused disability were as 0.94% and 0.63%, respectively. More than half of the co-morbid people were living with profound disabilities while 46.32% of the people living with both disabilities developed co-morbid disabilities in the same year. Data from the follow-up program showed that 56.25% of the people living with co-morbid disabilities did not receive any psychiatric treatment which were in need.
CONCLUSION: There seemed a close but bidirectional relationship existed between the mental disorders and injuries that calling for better mental health services provided for people with psychiatric disabilities.

Entities:  

Mesh:

Year:  2015        PMID: 25975547

Source DB:  PubMed          Journal:  Zhonghua Liu Xing Bing Xue Za Zhi        ISSN: 0254-6450


  1 in total

1.  Co-morbid mental disability among Chinese elderly with motor disability: Based on a nationwide survey.

Authors:  Chao Guo; Ping He; Xinming Song; Gong Chen; Xiaoying Zheng
Journal:  PLoS One       Date:  2018-04-05       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.